Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19
Stephen Hughes, Nabeela Mughal, Luke Moore
Antibiotics (2021) Vol. 10, Iss. 9, pp. 1119-1119
Open Access | Times Cited: 18

Showing 18 citing articles:

Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis
Bradley J. Langford, Miranda So, Marina Simeonova, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 3, pp. e179-e191
Open Access | Times Cited: 106
Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19
Lisa Hessels, Esther M. Speksnijder, Nienke Paternotte, et al.
CHEST Journal (2023) Vol. 164, Iss. 3, pp. 596-605
Open Access | Times Cited: 13
Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS
Owen Richards, Philip Pallmann, Charles C. King, et al.
Antibiotics (2021) Vol. 10, Iss. 11, pp. 1425-1425
Open Access | Times Cited: 27
Bacterial and Fungal Co-Infections and Superinfections in a Cohort of COVID-19 Patients: Real-Life Data from an Italian Third Level Hospital
Manuela Ceccarelli, Andrea Marıno, Sarah Pulvirenti, et al.
Infectious Disease Reports (2022) Vol. 14, Iss. 3, pp. 372-382
Open Access | Times Cited: 14
Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
Huan-Yi Wu, Peng-Hao Chang, Yu‐Shan Huang, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 2, pp. 207-235
Open Access | Times Cited: 14
Fungal–Bacterial Co-Infections and Super-Infections among Hospitalized COVID-19 Patients: A Systematic Review
Farkad Bantun
Journal of Fungi (2023) Vol. 9, Iss. 6, pp. 598-598
Open Access | Times Cited: 5
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations
Andrea Lay‐Hoon Kwa, B. Rina A. Sidharta, Do Ngoc Son, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 22, Iss. 1-3, pp. 45-58
Open Access | Times Cited: 4
C-reactive protein-guided use of procalcitonin in COVID-19
Rebecca Houghton, Nathan Moore, Rebecca Williams, et al.
JAC-Antimicrobial Resistance (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 11
The Association between Admission Procalcitonin Level and The Severity of COVID-19 Pneumonia: A Retrospective Cohort Study
Mohamed Aon, Abdullah Alsaeedi, Azeez Alzafiri, et al.
Medicina (2022) Vol. 58, Iss. 10, pp. 1389-1389
Open Access | Times Cited: 5
Procalcitonin as a Tool to Antimicrobial Stewardship in COVID-19 Patients with Superimposed Bacterial Infections: A Systematic Review
Ibrahim Omer, Noorah Abuthiyab, Nura Al Zaid, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 6055-6064
Open Access | Times Cited: 5
Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19
Avi J. Cohen, Laura Glick, Seohyuk Lee, et al.
European Clinical Respiratory Journal (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients—Results from a Retrospective Observational Study in Intensive Care Units
Giancarlo Ceccarelli, Francesco Alessandri, Giuseppe Migliara, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6171-6171
Open Access | Times Cited: 2
PROCAL: A SHap-based approach to explain Random Forest predictions of COVID-19- Procalcitonin levels
Muhammet Emin Naldan, Kevser Kübra Kırboğa, Mesut Işık, et al.
Research Square (Research Square) (2024)
Open Access
Are C-reactive protein and procalcitonin safe and useful for antimicrobial stewardship purposes in patients with COVID-19? A scoping review
Anita Williams, Ernestina Repetto, Ishmael Lebbie, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2024) Vol. 4, Iss. 1
Open Access
A Review of Potential Therapeutic Strategies for COVID-19
Jiajia Meng, Ruijiao Li, Zhiqi Zhang, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2346-2346
Open Access | Times Cited: 3
Procalcitonin Testing With Secondary Coinfection in Patients With COVID-19
Rashid Nadeem, Hind M Aljaghber, Doaa Elgohary, et al.
Cureus (2022)
Open Access | Times Cited: 1
Nonutility of procalcitonin for diagnosing bacterial pneumonia in COVID-19
Avi J. Cohen, Laura Glick, Seohyuk Lee, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Formes cliniques et organisation des soins contre la maladie à coronavirus 2019 (Covid-19)
L. Kassegne, Philippe Fraisse
Encyclopédie médico-chirurgicale. Pneumologie (2022) Vol. 33, Iss. 3, pp. 1-11
Closed Access
Page 1

Scroll to top